Carleton M. Sherman

448 total citations
9 papers, 354 citations indexed

About

Carleton M. Sherman is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Carleton M. Sherman has authored 9 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in Carleton M. Sherman's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (6 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Carleton M. Sherman is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (6 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Carleton M. Sherman collaborates with scholars based in United States, South Africa and India. Carleton M. Sherman's co-authors include Tawanda Gumbo, Shashikant Srivastava, Richard D. Leff, Claudia Meek, Devyani Deshpande, Jotam G. Pasipanodya, Thearith Koeuth, Prithvi Raj, Edward K. Wakeland and Gesham Magombedze and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Carleton M. Sherman

9 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carleton M. Sherman United States 8 288 228 114 63 58 9 354
Jeannine du Bois United States 6 310 1.1× 196 0.9× 76 0.7× 75 1.2× 22 0.4× 6 384
Sung Choi South Korea 10 144 0.5× 111 0.5× 46 0.4× 107 1.7× 56 1.0× 21 346
Shu’an Wen China 13 293 1.0× 238 1.0× 23 0.2× 144 2.3× 21 0.4× 22 425
Yoji Nagasaki Japan 10 242 0.8× 190 0.8× 35 0.3× 36 0.6× 40 0.7× 31 349
Zhaojing Zong China 10 332 1.2× 278 1.2× 18 0.2× 127 2.0× 47 0.8× 17 398
Justin Bader United States 10 227 0.8× 168 0.7× 85 0.7× 32 0.5× 58 1.0× 26 321
Sheila Duncan United States 5 99 0.3× 209 0.9× 177 1.6× 40 0.6× 82 1.4× 11 333
Fabrice Betoudji United States 8 208 0.7× 142 0.6× 23 0.2× 91 1.4× 29 0.5× 9 259
Hannah Yejin Kim Australia 13 160 0.6× 107 0.5× 83 0.7× 54 0.9× 9 0.2× 34 321
Nicola Farrington United Kingdom 9 151 0.5× 171 0.8× 119 1.0× 35 0.6× 90 1.6× 14 300

Countries citing papers authored by Carleton M. Sherman

Since Specialization
Citations

This map shows the geographic impact of Carleton M. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carleton M. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carleton M. Sherman more than expected).

Fields of papers citing papers by Carleton M. Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carleton M. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carleton M. Sherman. The network helps show where Carleton M. Sherman may publish in the future.

Co-authorship network of co-authors of Carleton M. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Carleton M. Sherman. A scholar is included among the top collaborators of Carleton M. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carleton M. Sherman. Carleton M. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gumbo, Tawanda, Carleton M. Sherman, Devyani Deshpande, Jan‐Willem C. Alffenaar, & Shashikant Srivastava. (2021). Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration. International Journal of Infectious Diseases. 104. 680–684. 8 indexed citations
2.
Srivastava, Shashikant, Devyani Deshpande, Carleton M. Sherman, & Tawanda Gumbo. (2017). A ‘shock and awe’ thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium–intracellulare complex disease. Journal of Antimicrobial Chemotherapy. 72(suppl_2). i43–i47. 14 indexed citations
3.
Srivastava, Shashikant, Gesham Magombedze, Thearith Koeuth, et al.. (2017). Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis. Antimicrobial Agents and Chemotherapy. 61(8). 85 indexed citations
4.
Srivastava, Shashikant, Jotam G. Pasipanodya, Geetha Ramachandran, et al.. (2016). A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies. EBioMedicine. 6. 126–138. 38 indexed citations
5.
Srivastava, Shashikant, Jotam G. Pasipanodya, Carleton M. Sherman, et al.. (2015). Rapid Drug Tolerance and Dramatic Sterilizing Effect of Moxifloxacin Monotherapy in a Novel Hollow-Fiber Model of Intracellular Mycobacterium kansasii Disease. Antimicrobial Agents and Chemotherapy. 59(4). 2273–2279. 18 indexed citations
6.
Ferro, Beatriz E., Shashikant Srivastava, Devyani Deshpande, et al.. (2015). Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model. Antimicrobial Agents and Chemotherapy. 60(3). 1242–1248. 45 indexed citations
7.
Srivastava, Shashikant, Carleton M. Sherman, Claudia Meek, Richard D. Leff, & Tawanda Gumbo. (2011). Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium tuberculosis but to Better Antimicrobial Effect: a New Paradigm for Antituberculosis Drug Scheduling. Antimicrobial Agents and Chemotherapy. 55(11). 5085–5089. 37 indexed citations
8.
Srivastava, Shashikant, et al.. (2010). Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy inMycobacterium tuberculosisand the Pharmacokinetics and Pharmacodynamics of Ethambutol. The Journal of Infectious Diseases. 201(8). 1225–1231. 107 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeannine du Bois Breakdown of academic impact, for papers by Sung Choi Breakdown of academic impact, for papers by Shu’an Wen Breakdown of academic impact, for papers by Yoji Nagasaki Breakdown of academic impact, for papers by Zhaojing Zong Breakdown of academic impact, for papers by Justin Bader Breakdown of academic impact, for papers by Sheila Duncan Breakdown of academic impact, for papers by Fabrice Betoudji Breakdown of academic impact, for papers by Hannah Yejin Kim Breakdown of academic impact, for papers by Nicola Farrington
Rankless by CCL
2026